{"id":"combination-dscg-and-reproterol","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DSCG (disodium cromoglycate) is a mast cell stabilizer that prevents the release of histamine and other mediators from mast cells, thereby reducing inflammation. Reproterol, on the other hand, is a beta-2 adrenergic receptor agonist that stimulates the relaxation of bronchial smooth muscle, leading to bronchodilation.","oneSentence":"DSCG inhibits mast cell degranulation and reduces inflammation, while Reproterol is a beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:27:03.767Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT00777348","phase":"PHASE2","title":"To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2007-11","conditions":"Asthma, Exercise-Induced","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Combination DSCG and Reproterol","genericName":"Combination DSCG and Reproterol","companyName":"MEDA Pharma GmbH & Co. KG","companyId":"meda-pharma-gmbh-co-kg","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DSCG inhibits mast cell degranulation and reduces inflammation, while Reproterol is a beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle. Used for Asthma, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}